Arabic Arabic English English French French German German
dark

Diving into Medtech's M&A in 2021

Glenn Hunzinger, US Pharma & Life Science Leader for PricewaterhouseCoopers discusses the Pharmaceutical and life sciences deals insights: 2021 midyear outlook report. Hunzinger also talks about some trends in medtech M&A and the rise of the Special Purpose Acquisition Corporation mergers. Plus, MD+DI’s Omar Ford gives insight on Illumina’s controversial acquisition of Grail. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

For or Against Vax? We Missed the Boat with Covid … Don’t Miss The “Opportunity of a Lifetime” Do Over

Next Post

GenBank release 245.0

Related Posts
Total
0
Share